nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfamethizole—ALB—liver cancer	0.97	1	CbGaD
Sulfamethizole—Sulfamethoxazole—NAT2—liver cancer	0.00273	0.284	CrCbGaD
Sulfamethizole—Dapsone—NAT2—liver cancer	0.00214	0.222	CrCbGaD
Sulfamethizole—Sulfamethazine—ALB—liver cancer	0.00101	0.105	CrCbGaD
Sulfamethizole—Sulfadiazine—CYP2E1—liver cancer	0.00101	0.105	CrCbGaD
Sulfamethizole—Sulfamerazine—ALB—liver cancer	0.000991	0.103	CrCbGaD
Sulfamethizole—ALB—Recycling of bile acids and salts—NR1H4—liver cancer	0.000983	0.0482	CbGpPWpGaD
Sulfamethizole—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—liver cancer	0.0007	0.0343	CbGpPWpGaD
Sulfamethizole—Sulfanilamide—CYP2E1—liver cancer	0.000688	0.0716	CrCbGaD
Sulfamethizole—ALB—FOXA2 and FOXA3 transcription factor networks—TAT—liver cancer	0.000667	0.0327	CbGpPWpGaD
Sulfamethizole—Dapsone—CYP2E1—liver cancer	0.000614	0.0639	CrCbGaD
Sulfamethizole—CYP2C9—CYP2E1 reactions—CYP2E1—liver cancer	0.000591	0.029	CbGpPWpGaD
Sulfamethizole—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—liver cancer	0.000548	0.0269	CbGpPWpGaD
Sulfamethizole—ALB—Bile acid and bile salt metabolism—NR1H4—liver cancer	0.000514	0.0252	CbGpPWpGaD
Sulfamethizole—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—liver cancer	0.000499	0.0245	CbGpPWpGaD
Sulfamethizole—CYP2C9—Constitutive Androstane Receptor Pathway—NR1I3—liver cancer	0.000454	0.0223	CbGpPWpGaD
Sulfamethizole—ALB—FOXA2 and FOXA3 transcription factor networks—CPT1B—liver cancer	0.000454	0.0222	CbGpPWpGaD
Sulfamethizole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1H4—liver cancer	0.00044	0.0216	CbGpPWpGaD
Sulfamethizole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I3—liver cancer	0.000433	0.0212	CbGpPWpGaD
Sulfamethizole—Sulfamethoxazole—ALB—liver cancer	0.000431	0.0448	CrCbGaD
Sulfamethizole—CYP2C9—Constitutive Androstane Receptor Pathway—GSTA2—liver cancer	0.000405	0.0199	CbGpPWpGaD
Sulfamethizole—ALB—Selenium Micronutrient Network—EPT1—liver cancer	0.000404	0.0198	CbGpPWpGaD
Sulfamethizole—CYP2C9—Xenobiotics—CYP2E1—liver cancer	0.000367	0.018	CbGpPWpGaD
Sulfamethizole—CYP2C9—Tamoxifen metabolism—CYP2E1—liver cancer	0.000353	0.0173	CbGpPWpGaD
Sulfamethizole—ALB—FOXA2 and FOXA3 transcription factor networks—ALDOB—liver cancer	0.000351	0.0172	CbGpPWpGaD
Sulfamethizole—ALB—FOXA2 and FOXA3 transcription factor networks—HNF4A—liver cancer	0.000298	0.0146	CbGpPWpGaD
Sulfamethizole—CYP2C9—Cytochrome P450 - arranged by substrate type—NR1H4—liver cancer	0.000279	0.0137	CbGpPWpGaD
Sulfamethizole—ALB—Binding and Uptake of Ligands by Scavenger Receptors—COL1A1—liver cancer	0.000274	0.0135	CbGpPWpGaD
Sulfamethizole—CYP2C9—Xenobiotics—CYP1A1—liver cancer	0.000263	0.0129	CbGpPWpGaD
Sulfamethizole—CYP2C9—Tamoxifen metabolism—CYP1A1—liver cancer	0.000253	0.0124	CbGpPWpGaD
Sulfamethizole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—liver cancer	0.00024	0.0118	CbGpPWpGaD
Sulfamethizole—CYP2C9—Phase 1 - Functionalization of compounds—NR1H4—liver cancer	0.000227	0.0111	CbGpPWpGaD
Sulfamethizole—ALB—Folate Metabolism—GPX3—liver cancer	0.000225	0.011	CbGpPWpGaD
Sulfamethizole—CYP2C9—Arachidonic acid metabolism—HPGDS—liver cancer	0.000216	0.0106	CbGpPWpGaD
Sulfamethizole—CYP2C9—Biological oxidations—UGDH—liver cancer	0.000206	0.0101	CbGpPWpGaD
Sulfamethizole—ALB—Platelet degranulation—SERPINA1—liver cancer	0.00019	0.00931	CbGpPWpGaD
Sulfamethizole—ALB—Response to elevated platelet cytosolic Ca2+—SERPINA1—liver cancer	0.000181	0.00887	CbGpPWpGaD
Sulfamethizole—ALB—Selenium Micronutrient Network—GPX3—liver cancer	0.000179	0.00876	CbGpPWpGaD
Sulfamethizole—CYP2C9—Arachidonic acid metabolism—GGT1—liver cancer	0.000162	0.00793	CbGpPWpGaD
Sulfamethizole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—liver cancer	0.000158	0.00773	CbGpPWpGaD
Sulfamethizole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2E1—liver cancer	0.000152	0.00746	CbGpPWpGaD
Sulfamethizole—CYP2C9—Oxidation by Cytochrome P450—CYP2E1—liver cancer	0.00015	0.00737	CbGpPWpGaD
Sulfamethizole—ALB—Vitamin B12 Metabolism—MTHFR—liver cancer	0.000142	0.00696	CbGpPWpGaD
Sulfamethizole—ALB—FOXA2 and FOXA3 transcription factor networks—F2—liver cancer	0.00014	0.00687	CbGpPWpGaD
Sulfamethizole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	0.00013	0.00639	CbGpPWpGaD
Sulfamethizole—CYP2C9—Arachidonic acid metabolism—CYP1A1—liver cancer	0.000127	0.0062	CbGpPWpGaD
Sulfamethizole—ALB—Selenium Micronutrient Network—GGT1—liver cancer	0.000126	0.00616	CbGpPWpGaD
Sulfamethizole—ALB—Vitamin B12 Metabolism—F2—liver cancer	0.000125	0.00611	CbGpPWpGaD
Sulfamethizole—CYP2C9—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.000123	0.00605	CbGpPWpGaD
Sulfamethizole—ALB—SLC-mediated transmembrane transport—SLC11A2—liver cancer	0.000122	0.00599	CbGpPWpGaD
Sulfamethizole—ALB—Transmembrane transport of small molecules—MYO5B—liver cancer	0.000121	0.00594	CbGpPWpGaD
Sulfamethizole—ALB—Transmembrane transport of small molecules—SLC9C1—liver cancer	0.000121	0.00594	CbGpPWpGaD
Sulfamethizole—CYP2C9—Biological oxidations—NR1H4—liver cancer	0.00012	0.0059	CbGpPWpGaD
Sulfamethizole—ALB—Platelet degranulation—IGF2—liver cancer	0.000119	0.00581	CbGpPWpGaD
Sulfamethizole—CYP2C9—Biological oxidations—GSTA3—liver cancer	0.000118	0.0058	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metapathway biotransformation—GSTA3—liver cancer	0.000117	0.00572	CbGpPWpGaD
Sulfamethizole—ALB—SLC-mediated transmembrane transport—SLC40A1—liver cancer	0.000117	0.00571	CbGpPWpGaD
Sulfamethizole—ALB—Folate Metabolism—MTHFR—liver cancer	0.000115	0.00566	CbGpPWpGaD
Sulfamethizole—ALB—Response to elevated platelet cytosolic Ca2+—IGF2—liver cancer	0.000113	0.00554	CbGpPWpGaD
Sulfamethizole—ALB—Platelet degranulation—HGF—liver cancer	0.000112	0.00549	CbGpPWpGaD
Sulfamethizole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.000109	0.00536	CbGpPWpGaD
Sulfamethizole—CYP2C9—Biological oxidations—GSTA4—liver cancer	0.000108	0.0053	CbGpPWpGaD
Sulfamethizole—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.000108	0.00529	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metapathway biotransformation—GSTA4—liver cancer	0.000107	0.00523	CbGpPWpGaD
Sulfamethizole—ALB—Response to elevated platelet cytosolic Ca2+—HGF—liver cancer	0.000107	0.00523	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—HBE1—liver cancer	0.000106	0.0052	CbGpPWpGaD
Sulfamethizole—CYP2C9—Biological oxidations—GSTA2—liver cancer	0.000105	0.00517	CbGpPWpGaD
Sulfamethizole—ALB—Vitamin B12 Metabolism—SERPINE1—liver cancer	0.000104	0.00508	CbGpPWpGaD
Sulfamethizole—CYP2C9—Biological oxidations—GSTA1—liver cancer	0.000102	0.00499	CbGpPWpGaD
Sulfamethizole—ALB—Folate Metabolism—F2—liver cancer	0.000101	0.00497	CbGpPWpGaD
Sulfamethizole—CYP2C9—Biological oxidations—NAT2—liver cancer	0.000101	0.00493	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metapathway biotransformation—NAT2—liver cancer	9.92e-05	0.00486	CbGpPWpGaD
Sulfamethizole—ALB—Selenium Micronutrient Network—MTHFR—liver cancer	9.17e-05	0.0045	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism of lipids and lipoproteins—EPT1—liver cancer	9.08e-05	0.00445	CbGpPWpGaD
Sulfamethizole—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	8.87e-05	0.00435	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metapathway biotransformation—GPX3—liver cancer	8.43e-05	0.00414	CbGpPWpGaD
Sulfamethizole—ALB—Folate Metabolism—SERPINE1—liver cancer	8.43e-05	0.00413	CbGpPWpGaD
Sulfamethizole—ALB—Platelet activation, signaling and aggregation—SERPINA1—liver cancer	8.43e-05	0.00413	CbGpPWpGaD
Sulfamethizole—ALB—Selenium Micronutrient Network—F2—liver cancer	8.05e-05	0.00395	CbGpPWpGaD
Sulfamethizole—CYP2C9—Biological oxidations—HPGDS—liver cancer	8.04e-05	0.00394	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism of lipids and lipoproteins—EPT1—liver cancer	7.44e-05	0.00365	CbGpPWpGaD
Sulfamethizole—ALB—Platelet degranulation—SERPINE1—liver cancer	7.23e-05	0.00354	CbGpPWpGaD
Sulfamethizole—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—liver cancer	6.89e-05	0.00338	CbGpPWpGaD
Sulfamethizole—ALB—Folate Metabolism—IL2—liver cancer	6.82e-05	0.00335	CbGpPWpGaD
Sulfamethizole—ALB—Selenium Micronutrient Network—SERPINE1—liver cancer	6.7e-05	0.00328	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—ANXA2—liver cancer	6.56e-05	0.00321	CbGpPWpGaD
Sulfamethizole—CYP2C9—Biological oxidations—CYP2E1—liver cancer	6.56e-05	0.00321	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metapathway biotransformation—CYP2E1—liver cancer	6.46e-05	0.00317	CbGpPWpGaD
Sulfamethizole—ALB—Transmembrane transport of small molecules—SLC11A2—liver cancer	6.21e-05	0.00304	CbGpPWpGaD
Sulfamethizole—ALB—Vitamin B12 Metabolism—TNF—liver cancer	6.11e-05	0.003	CbGpPWpGaD
Sulfamethizole—CYP2C9—Biological oxidations—GGT1—liver cancer	6.02e-05	0.00295	CbGpPWpGaD
Sulfamethizole—ALB—Transmembrane transport of small molecules—SLC40A1—liver cancer	5.92e-05	0.0029	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	5.85e-05	0.00287	CbGpPWpGaD
Sulfamethizole—ALB—Transmembrane transport of small molecules—ANXA2—liver cancer	5.68e-05	0.00278	CbGpPWpGaD
Sulfamethizole—ALB—Transmembrane transport of small molecules—ATP7B—liver cancer	5.68e-05	0.00278	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	5.64e-05	0.00277	CbGpPWpGaD
Sulfamethizole—ALB—Platelet activation, signaling and aggregation—PRKCE—liver cancer	5.55e-05	0.00272	CbGpPWpGaD
Sulfamethizole—CYP2C9—Biological oxidations—GSTP1—liver cancer	5.41e-05	0.00265	CbGpPWpGaD
Sulfamethizole—ALB—Transmembrane transport of small molecules—NR1H4—liver cancer	5.37e-05	0.00263	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metapathway biotransformation—GSTP1—liver cancer	5.33e-05	0.00261	CbGpPWpGaD
Sulfamethizole—ALB—Platelet activation, signaling and aggregation—IGF2—liver cancer	5.26e-05	0.00258	CbGpPWpGaD
Sulfamethizole—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—liver cancer	5.12e-05	0.00251	CbGpPWpGaD
Sulfamethizole—ALB—Platelet degranulation—VEGFA—liver cancer	4.97e-05	0.00244	CbGpPWpGaD
Sulfamethizole—ALB—Folate Metabolism—TNF—liver cancer	4.97e-05	0.00244	CbGpPWpGaD
Sulfamethizole—CYP2C9—Biological oxidations—GSTM1—liver cancer	4.97e-05	0.00244	CbGpPWpGaD
Sulfamethizole—ALB—Platelet activation, signaling and aggregation—HGF—liver cancer	4.97e-05	0.00244	CbGpPWpGaD
Sulfamethizole—ALB—Vitamin B12 Metabolism—IL6—liver cancer	4.93e-05	0.00242	CbGpPWpGaD
Sulfamethizole—ALB—Platelet activation, signaling and aggregation—CSF2—liver cancer	4.91e-05	0.00241	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metapathway biotransformation—GSTM1—liver cancer	4.9e-05	0.0024	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	4.79e-05	0.00235	CbGpPWpGaD
Sulfamethizole—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—liver cancer	4.74e-05	0.00232	CbGpPWpGaD
Sulfamethizole—CYP2C9—Biological oxidations—CYP1A1—liver cancer	4.71e-05	0.00231	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metapathway biotransformation—CYP1A1—liver cancer	4.64e-05	0.00228	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	4.62e-05	0.00227	CbGpPWpGaD
Sulfamethizole—ALB—Platelet degranulation—TGFB1—liver cancer	4.56e-05	0.00224	CbGpPWpGaD
Sulfamethizole—ALB—Folate Metabolism—TP53—liver cancer	4.38e-05	0.00215	CbGpPWpGaD
Sulfamethizole—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—liver cancer	4.35e-05	0.00213	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—SERPINA1—liver cancer	4.34e-05	0.00213	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	4.32e-05	0.00212	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—UGDH—liver cancer	4.3e-05	0.00211	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—EPT1—liver cancer	4.05e-05	0.00198	CbGpPWpGaD
Sulfamethizole—ALB—Folate Metabolism—IL6—liver cancer	4.01e-05	0.00197	CbGpPWpGaD
Sulfamethizole—ALB—Platelet activation, signaling and aggregation—MAPK14—liver cancer	3.98e-05	0.00195	CbGpPWpGaD
Sulfamethizole—ALB—Selenium Micronutrient Network—TNF—liver cancer	3.95e-05	0.00194	CbGpPWpGaD
Sulfamethizole—ALB—Platelet activation, signaling and aggregation—F2—liver cancer	3.85e-05	0.00189	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—TAT—liver cancer	3.84e-05	0.00188	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	3.77e-05	0.00185	CbGpPWpGaD
Sulfamethizole—ALB—Platelet activation, signaling and aggregation—PIK3CG—liver cancer	3.69e-05	0.00181	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	3.53e-05	0.00173	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—UGDH—liver cancer	3.52e-05	0.00173	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—EPT1—liver cancer	3.31e-05	0.00162	CbGpPWpGaD
Sulfamethizole—ALB—Platelet activation, signaling and aggregation—PIK3CD—liver cancer	3.24e-05	0.00159	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—IFNA1—liver cancer	3.23e-05	0.00159	CbGpPWpGaD
Sulfamethizole—ALB—Platelet activation, signaling and aggregation—SERPINE1—liver cancer	3.21e-05	0.00157	CbGpPWpGaD
Sulfamethizole—ALB—Selenium Micronutrient Network—IL6—liver cancer	3.19e-05	0.00156	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—TAT—liver cancer	3.14e-05	0.00154	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	3.09e-05	0.00151	CbGpPWpGaD
Sulfamethizole—ALB—Platelet activation, signaling and aggregation—RAF1—liver cancer	2.89e-05	0.00142	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—PRKCE—liver cancer	2.86e-05	0.0014	CbGpPWpGaD
Sulfamethizole—ALB—Platelet activation, signaling and aggregation—PIK3CB—liver cancer	2.83e-05	0.00139	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism of lipids and lipoproteins—GGT1—liver cancer	2.82e-05	0.00138	CbGpPWpGaD
Sulfamethizole—ALB—Transmembrane transport of small molecules—CYCS—liver cancer	2.74e-05	0.00134	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—ABL1—liver cancer	2.72e-05	0.00134	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—IGF2—liver cancer	2.71e-05	0.00133	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—CPT1B—liver cancer	2.61e-05	0.00128	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—GLUL—liver cancer	2.61e-05	0.00128	CbGpPWpGaD
Sulfamethizole—ALB—Platelet activation, signaling and aggregation—IL2—liver cancer	2.6e-05	0.00127	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—HGF—liver cancer	2.56e-05	0.00126	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—CSF2—liver cancer	2.53e-05	0.00124	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—NR1H4—liver cancer	2.51e-05	0.00123	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—GSTA3—liver cancer	2.47e-05	0.00121	CbGpPWpGaD
Sulfamethizole—ALB—Transmembrane transport of small molecules—HMOX1—liver cancer	2.38e-05	0.00117	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—liver cancer	2.31e-05	0.00113	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—GSTA4—liver cancer	2.26e-05	0.00111	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	2.21e-05	0.00108	CbGpPWpGaD
Sulfamethizole—ALB—Platelet activation, signaling and aggregation—VEGFA—liver cancer	2.21e-05	0.00108	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—GSTA2—liver cancer	2.2e-05	0.00108	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—GLUL—liver cancer	2.13e-05	0.00105	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—CPT1B—liver cancer	2.13e-05	0.00105	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—GSTA1—liver cancer	2.13e-05	0.00104	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—NAT2—liver cancer	2.1e-05	0.00103	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—NR1H4—liver cancer	2.06e-05	0.00101	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—MAPK14—liver cancer	2.05e-05	0.00101	CbGpPWpGaD
Sulfamethizole—ALB—Platelet activation, signaling and aggregation—TGFB1—liver cancer	2.02e-05	0.000993	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—GSTA3—liver cancer	2.02e-05	0.000992	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.02e-05	0.000991	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—ALDOB—liver cancer	2.01e-05	0.000988	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—F2—liver cancer	1.99e-05	0.000974	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—CRABP1—liver cancer	1.92e-05	0.000942	CbGpPWpGaD
Sulfamethizole—ALB—Transmembrane transport of small molecules—PPARA—liver cancer	1.92e-05	0.000942	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—PIK3CG—liver cancer	1.9e-05	0.000932	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—GSTA4—liver cancer	1.85e-05	0.000907	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	1.81e-05	0.000887	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—GSTA2—liver cancer	1.8e-05	0.000884	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—GSTA1—liver cancer	1.74e-05	0.000853	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.73e-05	0.000849	CbGpPWpGaD
Sulfamethizole—ALB—Platelet activation, signaling and aggregation—PIK3CA—liver cancer	1.72e-05	0.000845	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—NAT2—liver cancer	1.72e-05	0.000843	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—HPGDS—liver cancer	1.68e-05	0.000824	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—PIK3CD—liver cancer	1.67e-05	0.000819	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.67e-05	0.000819	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	1.65e-05	0.000811	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—SERPINE1—liver cancer	1.65e-05	0.00081	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—ALDOB—liver cancer	1.65e-05	0.000809	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—CRABP1—liver cancer	1.57e-05	0.000771	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.52e-05	0.000746	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—PSMD10—liver cancer	1.5e-05	0.000734	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—PSMA4—liver cancer	1.5e-05	0.000734	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—RAF1—liver cancer	1.49e-05	0.000731	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—GOT2—liver cancer	1.46e-05	0.000714	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—PIK3CB—liver cancer	1.46e-05	0.000714	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.42e-05	0.000695	CbGpPWpGaD
Sulfamethizole—ALB—Platelet activation, signaling and aggregation—AKT1—liver cancer	1.41e-05	0.00069	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—HPGDS—liver cancer	1.38e-05	0.000674	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—CYP2E1—liver cancer	1.37e-05	0.000671	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.37e-05	0.00067	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—IL2—liver cancer	1.34e-05	0.000656	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.33e-05	0.00065	CbGpPWpGaD
Sulfamethizole—ALB—Transmembrane transport of small molecules—RAF1—liver cancer	1.29e-05	0.000633	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—CYCS—liver cancer	1.28e-05	0.000628	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—GGT1—liver cancer	1.26e-05	0.000617	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—GOT1—liver cancer	1.26e-05	0.000617	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.25e-05	0.000611	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.23e-05	0.000603	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—PSMD10—liver cancer	1.23e-05	0.000601	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—PSMA4—liver cancer	1.23e-05	0.000601	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—GOT2—liver cancer	1.19e-05	0.000585	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—VEGFA—liver cancer	1.14e-05	0.000557	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—GSTP1—liver cancer	1.13e-05	0.000554	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—CYP2E1—liver cancer	1.12e-05	0.00055	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—HMOX1—liver cancer	1.11e-05	0.000546	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.09e-05	0.000532	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—CYCS—liver cancer	1.05e-05	0.000514	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—TGFB1—liver cancer	1.04e-05	0.000512	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—GSTM1—liver cancer	1.04e-05	0.000509	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—GOT1—liver cancer	1.03e-05	0.000505	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—GGT1—liver cancer	1.03e-05	0.000505	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—CYP1A1—liver cancer	9.84e-06	0.000482	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—KRAS—liver cancer	9.66e-06	0.000474	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—GSTP1—liver cancer	9.24e-06	0.000453	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—MTHFR—liver cancer	9.17e-06	0.00045	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—HMOX1—liver cancer	9.12e-06	0.000447	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—PPARA—liver cancer	9e-06	0.000441	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—PIK3CA—liver cancer	8.88e-06	0.000435	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—TP53—liver cancer	8.59e-06	0.000421	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—GSTM1—liver cancer	8.5e-06	0.000417	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—HRAS—liver cancer	8.21e-06	0.000403	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	8.08e-06	0.000396	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—CYP1A1—liver cancer	8.05e-06	0.000395	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—PIK3CG—liver cancer	7.71e-06	0.000378	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—MTHFR—liver cancer	7.51e-06	0.000368	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—PPARG—liver cancer	7.44e-06	0.000365	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—PPARA—liver cancer	7.37e-06	0.000361	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—AKT1—liver cancer	7.25e-06	0.000356	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—PIK3CD—liver cancer	6.78e-06	0.000332	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	6.62e-06	0.000324	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—PIK3CG—liver cancer	6.31e-06	0.000309	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—PPARG—liver cancer	6.09e-06	0.000299	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—PIK3CB—liver cancer	5.91e-06	0.00029	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—PIK3CD—liver cancer	5.55e-06	0.000272	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—ALB—liver cancer	5.47e-06	0.000268	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—PIK3CB—liver cancer	4.83e-06	0.000237	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—PIK3CA—liver cancer	3.6e-06	0.000177	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—PIK3CA—liver cancer	2.95e-06	0.000144	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—AKT1—liver cancer	2.94e-06	0.000144	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—AKT1—liver cancer	2.41e-06	0.000118	CbGpPWpGaD
